I
IONS icon

InceptionR’s Ionis Pharmaceuticals IONS Stock Holding History

InceptionR’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.92M Buy
24,251
+7,430
+44% +$559K 0.47% 10
2026
Q1 		$1.26M Sell
16,821
-1,029
-6% -$81.2K 0.3% 91
2025
Q4 		$1.41M Buy
17,850
+10,229
+134% +$770K 0.39% 41
2025
Q3 		$499K Buy
+7,621
New +$372K 0.12% 312
2025
Q1 		– Sell
-14,390
Closed -$503K – 692
2024
Q4 		$503K Buy
+14,390
New +$538K 0.11% 332
2024
Q3 		– Sell
-17,289
Closed -$824K – 755
2024
Q2 		$824K Buy
+17,289
New +$709K 0.23% 152
2023
Q2 		– Sell
-12,790
Closed -$457K – 516
2023
Q1 		$457K Buy
+12,790
New +$480K 0.15% 261

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

InceptionR's IONS Position: Q2 2026 in Review

InceptionR increased its Ionis Pharmaceuticals (IONS) stake by 44% in Q2 2026, buying an estimated $559K and bringing the position to 24,251 shares worth $1.92M. The position accounts for 0.47% of the portfolio, ranked #10.

InceptionR first reported a position in IONS in Q1 2023 and has held it in 7 quarters since. 513 funds tracked by Wall St. Rank hold IONS as of Q2 2026.

  • InceptionR held 24,251 shares of Ionis Pharmaceuticals worth $1.92M as of Q2 2026.
  • InceptionR bought 7,430 Ionis Pharmaceuticals shares in Q2 2026, an estimated $559K.
  • Ionis Pharmaceuticals made up 0.47% of InceptionR's portfolio in Q2 2026, its #10 holding.
  • InceptionR first reported a position in Ionis Pharmaceuticals in Q1 2023 and has held it in 7 quarters since.
  • 513 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2026.

Based on InceptionR's 13F filing for Q2 2026, filed 11 Aug 2026.